18.300USD+18.300æéå€ååŒÂ 08/03, 20:00 (ET)
368.70MæäŸ¡ç·é¡
æå€±é¡çŽè¿12ã¶æPER
äž»èŠããŒã¿
18.310å§å€
18.340é«å€
377.98Kåºæ¥é«
æå€±é¡çŽè¿12ã¶æPER
31.96äºæ³PER
--çŽè¿12ã¶æé
åœ
1.87%売買å転ç
18.300忥çµå€
18.220å®å€
4.59M売買代é
æå€±é¡æ ªäŸ¡åçç
2.65PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-36.09%ç·è³ç£å©çç
32.51552é±é«å€
1.27åºæ¥é«æ¯ç%
-64.72MçŽå©ç
20.22Mæ ªåŒæ°
-3.12441æ ªåœããå©çïŒEPSïŒ
1.31ããŒã¿å€
-38.84%èªå·±è³æ¬å©çç
11.09052é±å®å€
0.66%æ¯ãå¹
65.27%ç²å©çç
368.70MæäŸ¡ç·é¡
-0.10ãªã¹ã¯ãªã¿ãŒã³
3.14%ãªã¹ã¯ç
é貚: USD æŽæ°æå»: 2026-07-31 äž»èŠã€ã³ãµã€ã
Simulations Plus Incã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯æ¯èŒçéåžžã«å¥å
šã§ããæé·ã®å¯èœæ§ã¯é«ãã§ããããªã¥ãšãŒã·ã§ã³ã¯é©æ£äŸ¡æ Œãšè©äŸ¡ãããŠããŸããå»çæ©åš & å忥çã§ã®é äœã¯199äž104äœã§ããæ©é¢æè³å®¶ä¿æçã¯éåžžã«é«ãã§ããéå»1ãæéã«è€æ°ã®ã¢ããªã¹ããããŒã«ããšè©äŸ¡ããæé«ç®æšæ ªäŸ¡ã¯19.83ãšãããŠããŸããäžæçã«ã¯ãæ ªäŸ¡ã¯äžæãã¬ã³ããšäºæ³ãããŸããéå»1ãæã®æ ªåŒåžå Žã®ããã©ãŒãã³ã¹ã¯å¹³åçã§ããããå瀟ã®ãã¡ã³ãã¡ã³ã¿ã«ãºã¯å
調ã§ããæ ªäŸ¡ã¯æ¯æç·ã𿵿ç·ã®éã§æšªã°ãæšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
Simulations Plus Incã®ã¹ã³ã¢î°î°
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
éåžžã«äœã
éåžžã«é«ã
Simulations Plus Incã®æ³šç®ãã€ã³ã
匷ã¿ãªã¹ã¯
Simulations Plus Inc ãã¥ãŒã¹
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
åçäºæž¬î
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
ææšî
ææš
売ã(2)
äžç«(3)
è²·ã(0)
ç§»åå¹³å
売ã(3)
äžç«(0)
è²·ã(3)
è²¡åææšî
EPS

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
ç·å£²äžé«

äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
Simulations Plus Incã®äŒæ¥æ
å ±î
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Companyâs business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
äŒæ¥ã³ãŒãSLP
äŒæ¥åSimulations Plus Inc
æé«çµå¶è²¬ä»»è
ãCEOãO'Connor (Shawn M)
ãŠã§ããµã€ãhttps://www.simulations-plus.com/
æ ªäž»çµ±èšî
ãããã質å
Simulations Plus IncïŒSLPïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îSimulations Plus IncïŒSLPïŒã®çŸåšã®æ ªäŸ¡ã¯18.23ã§ãã
Simulations Plus Incã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îSimulations Plus Incã®ãã£ãã«ãŒã·ã³ãã«ã¯SLPã§ãã
Simulations Plus Incã®52é±é«å€ã¯ãããã§ããïŒ
îSimulations Plus Incã®52é±é«å€ã¯32.52ã§ãã
Simulations Plus Incã®52é±å®å€ã¯ãããã§ããïŒ
îSimulations Plus Incã®52é±å®å€ã¯11.09ã§ãã
Simulations Plus Incã®æäŸ¡ç·é¡ã¯ãããã§ããïŒ
îSimulations Plus Incã®æäŸ¡ç·é¡ã¯368.70Mã§ãã
Simulations Plus Inc (SLP) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãSimulations Plus IncïŒSLPïŒã®ç·åè©äŸ¡ã¯signal_holdã§ãç®æšæ ªäŸ¡ã¯19.83ã§ãã
Simulations Plus Inc (SLP) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îSimulations Plus IncïŒSLPïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-3.22ã§ãã